Moreover, in NSCLC, SOX2 and p53 are part of a different panel of auto-antibodies (SOX2, GAGE 7, MAGE A1, and p53), found to be increased in a set of NSCLC [85]. Here, SOX2 is linked to non-small cell lung carcinoma.